DIA
RMD icon

Dean Investment Associates’s ResMed RMD Stock Holding History

Dean Investment Associates’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-13,686
Closed -$791K – 219
2016
Q1 		$791K Buy
13,686
+546
+4% +$30.9K 0.16% 133
2015
Q4 		$705K Buy
13,140
+446
+4% +$25.1K 0.16% 137
2015
Q3 		$647K Buy
+12,694
New +$683K 0.15% 146

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
CBOA
Commonwealth Bank of Australia Sydney, NSW, Australia $231M AUM
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
PP
Prudential plc London, England, United Kingdom $17.1B AUM 15.7% 1-Year Est. Return

Dean Investment Associates's RMD Position: Q2 2016 in Review

Dean Investment Associates sold out of ResMed (RMD) in Q2 2016, closing a stake of 13,686 shares — an estimated $791K sold.

Dean Investment Associates first reported a position in RMD in Q3 2015 and held it in 3 quarters. The position peaked at $791K in Q1 2016. 361 funds tracked by Wall St. Rank hold RMD as of Q2 2016.

  • Dean Investment Associates reported no remaining ResMed position as of Q2 2016 after selling out during the quarter.
  • Dean Investment Associates sold 13,686 ResMed shares in Q2 2016, an estimated $791K.
  • Dean Investment Associates first reported a position in ResMed in Q3 2015 and held it in 3 quarters.
  • Dean Investment Associates's ResMed position peaked at $791K in Q1 2016.
  • 361 funds tracked by Wall St. Rank held ResMed as of Q2 2016.

Based on Dean Investment Associates's 13F filing for Q2 2016, filed 3 Aug 2016.